Louisville, Colorado – October 1 – Synergy Spine Solutions, an innovative orthopaedic medical device company focused on artificial cervical disc replacement, today announced the expansion of its sales agency agreement with Johnson & Johnson MedTech Germany.
This agreement builds on the success of the existing sales agency agreements with Johnson & Johnson Medtech across the United Kingdom, the Republic of Ireland and Switzerland. The inclusion of Germany, a large & key European market for spine innovation, represents a strategic step forward in expanding access to the Synergy Disc® for spine surgeons and their patients.
The expansion of this sales relationship marks the continued momentum behind the Synergy Disc®, the only artificial cervical disc with a 6° lordotic core that combines cervical alignment and balance with natural motion for patients with degenerative disc disease (DDD) causing radiculopathy and / or myelopathy.
The unique design of the Synergy Disc® utilises time-tested materials that are aligned with the stringent standards of Johnson & Johnson MedTech and their role as a global leader in orthopaedic and spine technology.
The agreement reflects a shared commitment to bringing innovation to spine surgery and patients, through a strong commercial infrastructure, deep clinical knowledge, and surgeon-first focus.
About Synergy Spine Solutions
The Vision of Synergy Spine Solutions is to identify and commercialize innovative spine technologies that help surgeons improve their patients’ quality of life and advance the standard of care. The company’s flagship product, the Synergy Disc, is the only device that is designed to restore both motion and alignment to the spine.Website: https://synergyspinesolutions.com/